Want to join the conversation?
Data analytics and risk assessment firm $VRSK reported a higher quarterly profit, helped by strong revenue growth and higher margins. The company reported 2Q16 earnings of $261.74MM, or $1.53 per share, compared with $163.32, or $0.97 per share a year ago. Revenue rose 16% to $498.30MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?